Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2005Antiviral Therapy

Nevirapine and Efavirenz Pharmacokinetics and Covariate Analysis in the 2Nn Study

View Full Paper
Ask AI
Bookmark
Share

Authors

BKBregt S KappelhoffBoehringer Ingelheim (Netherlands)FLFrank van LethAmsterdam Institute for Global Health and DevelopmentTMThomas R. MacGregorUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kappelhoff et al. (2005) studied this question.

synapsesocial.com/papers/6a900a35c7b7d4543f89cecahttps://doi.org/10.1177/135965350501000114
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection2003 · 267 citations
  2. 2Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults1999 · 1,010 citations
  3. 3CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4*1B 5′-promoter region polymorphism2000 · 248 citations
  4. 4A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients1998 · 776 citations
  5. 5Population Pharmacokinetics and Pharmacodynamics of Efavirenz, Nelfinavir, and Indinavir: Adult AIDS Clinical Trial Group Study 3982002 · 129 citations